These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 14475542

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Experimental evaluation of potential anticancer agents. IX. The ribonucleosides and ribonucleotides of two purine antagonists.
    MONTGOMERY JA, SCHABEL FM, SKIPPER HE.
    Cancer Res; 1962 May; 22():504-9. PubMed ID: 14475543
    [No Abstract] [Full Text] [Related]

  • 3. Studies on the mode of action of 6-mercaptopurine and its ribonucleoside on mammalian cells in culture.
    HAKALA MT, NICHOL CA.
    J Biol Chem; 1959 Dec; 234():3224-8. PubMed ID: 14398912
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Arabinosyl-6-mercaptopurine and arabinosyl-6-mercaptopurine-5'-phosphate: comparison of their metabolic effects.
    LePage GA, Bell JP, Wilson MJ.
    Proc Soc Exp Biol Med; 1969 Jul; 131(3):1038-41. PubMed ID: 5791773
    [No Abstract] [Full Text] [Related]

  • 6. Reversal by ribonucleosides of bacterial growth inhibition caused by alcohol.
    LANSFORD EM, HILL ID, SHIVE W.
    J Biol Chem; 1960 Dec; 235():3551-5. PubMed ID: 13758937
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of triphosphate nucleosides of 8-azaguanine, 6-thioguanine, and 6-mercaptopurine on amino acid incorporation in vitro into microsomal protein.
    ROY JK, KVAM DC, DAHL JL, PARKS RE.
    J Biol Chem; 1961 Apr; 236():1158-62. PubMed ID: 13744194
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A synopsis of recent investigations of 5-iodo-2'-deoxyuridine.
    WELCH AD, PRUSOFF WH.
    Cancer Chemother Rep; 1960 Feb; 6():29-36. PubMed ID: 13843820
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacological and clinical studies with triacetyl 6-azauridine.
    HANDSCHUMACHER RE, CREASEY WA, FINK ME, CALABRESI P, WELCH AD.
    Cancer Chemother Rep; 1962 Feb; 16():267-9. PubMed ID: 13904322
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [On the carcinostatic effect of 6-azauracil and of its ribosides. Studies on the effect of 6-azauracil and of its ribosides on the activity of normal tissues].
    HABERMANN V.
    Cesk Fysiol; 1959 Jul; 8():326-7. PubMed ID: 13830676
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The potentiation by 5-iodo-2'-deoxyuridine (IUDR) of the tumor-inhibitory activity of 5-fluoro-2'-deoxyuridine (FUDR).
    HEIDELBERGER C, GRIESBACH L, GHOBAR A.
    Cancer Chemother Rep; 1960 Feb; 6():37-8. PubMed ID: 14400595
    [No Abstract] [Full Text] [Related]

  • 18. Reversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenine.
    Stet EH, De Abreu RA, Bökkerink JP, Lambooy LH, Vogels-Mentink TM, Keizer-Garritsen JJ, Trijbels FJ.
    Biochem Pharmacol; 1995 Jan 06; 49(1):49-56. PubMed ID: 7840782
    [Abstract] [Full Text] [Related]

  • 19. A proposed mechanism of action of 1-beta-D-arabinofuranosyl-cytosine as an inhibitor of the growth of leukemic cells.
    CHU MY, FISCHER GA.
    Biochem Pharmacol; 1962 Jun 06; 11():423-30. PubMed ID: 13879359
    [No Abstract] [Full Text] [Related]

  • 20. Nucleoside and nucleotide modulation of genetic expression--a new approach to chemotherapy.
    Robins RK, Ojo-Amaize E, Parandoosh Z, Cottam HB, Matsumoto SS, Revankar GR, Smee DF, Fujitaki JM, Willis RC, Rubalcava B.
    Adv Enzyme Regul; 1989 Jun 06; 29():97-121. PubMed ID: 2517379
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.